Yonsei Med J.  2000 Dec;41(6):704-719. 10.3349/ymj.2000.41.6.704.

Cytokine delivery and tissue engineering

Affiliations
  • 1Department of Pharmacy, College of Pharmacy, Ewha Womans University, Seoul, Korea. sjlee@ewha.ac.kr

Abstract

Tissue engineering has been applied to various tissues, and particularly significant progress has been made in the areas of skin, cartilage, and bone regeneration. Inclusion of bioactive factors into the synthetic scaffolds has been suggested as one of the possible tissue engineering strategies. The growth factors are polypeptides that transmit signals to modulate cellular activities. They have short half-lives, for example, platelet-derived growth factor (PDGF), isolated from platelets, has a half life of less than 2 minutes when injected intravenously. Extended biological activity and the controlled release of growth factor are achieved by incorporating growth factor into the polymeric device. This review will focus on growth factor delivery for tissue engineering. Particular examples will be given whereby growth factors are delivered from a tissue-engineered device to facilitate wound healing and tissue repair.

Keyword

Cytokines; peptide delivery; vehicle

MeSH Terms

Animal
Biomedical Engineering/methods*
Bone Morphogenetic Proteins/administration & dosage
Cytokines/therapeutic use
Cytokines/administration & dosage*
Growth Substances/physiology

Cited by  1 articles

Effects of Polycaprolactone-Tricalcium Phosphate, Recombinant Human Bone Morphogenetic Protein-2 and Dog Mesenchymal Stem Cells on Bone Formation: Pilot Study in Dogs
Sun-Jong Kim, Myung-Rae Kim, Jin-Sub Oh, Inho Han, Sang-Wan Shin
Yonsei Med J. 2009;50(6):825-831.    doi: 10.3349/ymj.2009.50.6.825.

Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr